welcome
Reuters

Reuters

Health

Health

FDA sets new COVID booster guidelines requiring trials for approvals for healthy adults

Reuters
Summary
Nutrition label

80% Informative

FDA to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65 .

Vaccine makers have argued new placebo-controlled trials could delay availability of the shots until after their usefulness has passed.

FDA Commissioner Marty Makary and top U.S. vaccines regulator Vinay Prasad wrote in the New England Journal of Medicine .

Investors reacted favorably to the news and shares of COVID vaccine makers rose.

VR Score

91

Informative language

96

Neutral language

77

Article tone

formal

Language

English

Language complexity

58

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links